Dr. Tom Portillo, Veterinary Research and Consulting Services, and Dr. Nathan Meyer, Boehringer Ingelheim Animal Health, join AABP Executive Director Dr. Fred Gingrich to discuss the results of a recent study published in the Bovine Practitioner. The objectives of the study were to test a range of post-treatment intervals in cattle naturally infected with bovine respiratory disease (BRD) and treated with Zactran, a macrolide antimicrobial manufactured by Boehringer Ingelheim. The investigators also evaluated if there was a difference between dairy-beef cross animals versus native beef animals. Identifying the ideal post-treatment interval can improve antimicrobial stewardship, efficiently manage labor, and improve welfare of animals by minimizing the stress of handling and time away from the home pen. Clinical trials are an important research tool to demonstrate the use of a product in a field setting when animals are affected by BRD. This study demonstrated that a 6-day or 9-day treatment interval provided the best health outcomes. We also discuss the importance of the Bovine Practitioner as a journal that provides peer-reviewed research targeted to practicing veterinarians. We encourage practicing veterinarians to develop on-farm trials and tips for partnering with academic and industry colleagues to submit research for publication.
This podcast was sponsored by Boehringer Ingelheim Animal Health. Boehringer Ingelheim (BI) is a premier sponsor of the 54th AABP Annual Conference in Salt Lake City, Utah. Join us on Wednesday October 6 for the opening reception, sponsored by BI, from 6 to 9 pm in Ballroom E on the lower concourse of the Salt Palace Convention Center to enjoy drinks and heavy appetizers. We look forward to socializing in person again!
Find out more information about Boehringer Ingelheim here or information about their products for ruminants. Product information about Zactran ® (gamithromycin) can be found at this link.
Find out information about Veterinary Research and Consulting Services LLC by visiting their website.
The research article referenced in this podcast is available open access at this link.
View all episodes
By AABP
4.7
3030 ratings
Dr. Tom Portillo, Veterinary Research and Consulting Services, and Dr. Nathan Meyer, Boehringer Ingelheim Animal Health, join AABP Executive Director Dr. Fred Gingrich to discuss the results of a recent study published in the Bovine Practitioner. The objectives of the study were to test a range of post-treatment intervals in cattle naturally infected with bovine respiratory disease (BRD) and treated with Zactran, a macrolide antimicrobial manufactured by Boehringer Ingelheim. The investigators also evaluated if there was a difference between dairy-beef cross animals versus native beef animals. Identifying the ideal post-treatment interval can improve antimicrobial stewardship, efficiently manage labor, and improve welfare of animals by minimizing the stress of handling and time away from the home pen. Clinical trials are an important research tool to demonstrate the use of a product in a field setting when animals are affected by BRD. This study demonstrated that a 6-day or 9-day treatment interval provided the best health outcomes. We also discuss the importance of the Bovine Practitioner as a journal that provides peer-reviewed research targeted to practicing veterinarians. We encourage practicing veterinarians to develop on-farm trials and tips for partnering with academic and industry colleagues to submit research for publication.
This podcast was sponsored by Boehringer Ingelheim Animal Health. Boehringer Ingelheim (BI) is a premier sponsor of the 54th AABP Annual Conference in Salt Lake City, Utah. Join us on Wednesday October 6 for the opening reception, sponsored by BI, from 6 to 9 pm in Ballroom E on the lower concourse of the Salt Palace Convention Center to enjoy drinks and heavy appetizers. We look forward to socializing in person again!
Find out more information about Boehringer Ingelheim here or information about their products for ruminants. Product information about Zactran ® (gamithromycin) can be found at this link.
Find out information about Veterinary Research and Consulting Services LLC by visiting their website.
The research article referenced in this podcast is available open access at this link.
39,003 Listeners
154,252 Listeners
41,159 Listeners
38,066 Listeners
3,679 Listeners
7,081 Listeners
131 Listeners
72,147 Listeners
792 Listeners
220 Listeners
72 Listeners
21 Listeners
3,224 Listeners
24 Listeners
6 Listeners